LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

ABBV

185.23

-2.89%↓

NVO

74.38

-3.34%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

ABBV

185.23

-2.89%↓

NVO

74.38

-3.34%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

ABBV

185.23

-2.89%↓

NVO

74.38

-3.34%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

ABBV

185.23

-2.89%↓

NVO

74.38

-3.34%↓

UNH

308.61

+0.35%↑

LLY

791.36

-1.92%↓

JNJ

152.37

-1.77%↓

ABBV

185.23

-2.89%↓

NVO

74.38

-3.34%↓

UNH

308.61

+0.35%↑

Search

Cerus Corp

Closed

SectorHealthcare

1.31 -6.43

Overview

Share price change

24h

Current

Min

1.31

Max

1.4

Key metrics

By Trading Economics

Income

-5.2M

-7.7M

Sales

-7.6M

43M

EPS

-0.04

Profit margin

-17.85

Employees

614

EBITDA

-5.8M

-5.9M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+231.21% upside

Dividends

By Dow Jones

Next Earnings

31 Jul 2025

Market Stats

By TradingEconomics

Market Cap

9.6M

270M

Previous open

7.74

Previous close

1.31

News Sentiment

By Acuity

15%

85%

9 / 381 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

Cerus Corp Chart

Past performance is not a reliable indicator of future results.

Related News

17 Jun 2025, 14:44 UTC

Acquisitions, Mergers, Takeovers

Justice Department Orders Safran to Sell Assets to Proceed with Buy of Collins Aerospace Business

17 Jun 2025, 23:43 UTC

Market Talk

Nikkei May Fall Amid Uncertainty Over Israel-Iran Conflict -- Market Talk

17 Jun 2025, 23:34 UTC

Market Talk

Gold Steady, Underpinned by Ongoing Geopolitical Tensions -- Market Talk

17 Jun 2025, 23:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 Jun 2025, 23:22 UTC

Market Talk

Global Energy Roundup: Market Talk

17 Jun 2025, 23:22 UTC

Market Talk

Meridian Energy Set to Draw Line Under 'Annus Horribilis' -- Market Talk

17 Jun 2025, 23:17 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tourism Holdings Likely to Seek Higher Offer -- Market Talk

17 Jun 2025, 23:05 UTC

Market Talk

Fletcher Building Could Signal Improved Shareholder Returns -- Market Talk

17 Jun 2025, 23:05 UTC

Market Talk

Global Equities Roundup: Market Talk

17 Jun 2025, 22:58 UTC

Market Talk

Australian Treasurer Chalmers Expected to Outline Second-Term Reform Agenda -- Market Talk

17 Jun 2025, 22:55 UTC

Market Talk
Acquisitions, Mergers, Takeovers

XRG Has a Good Argument for Regulatory Approval of Santos Deal -- Market Talk

17 Jun 2025, 22:31 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Lifeway Foods CEO Not Surprised by Takeover Interest -- Market Talk

17 Jun 2025, 22:14 UTC

Major Market Movers

Bitdeer Technologies Group Shares Fall on Note Offering

17 Jun 2025, 19:49 UTC

Market Talk

Natural Gas Slow Down Gains -- Market Talk

17 Jun 2025, 19:34 UTC

Market Talk

Oil Rises On Israel-Iran Conflict Uncertainty -- Market Talk

17 Jun 2025, 19:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 Jun 2025, 19:10 UTC

Market Talk

Dollar Strengthens, Treasury Yields Fall in Risk-Off Trade -- Market Talk

17 Jun 2025, 18:41 UTC

Market Talk

Slowdown in US Consumer Spending Expected -- Market Talk

17 Jun 2025, 18:15 UTC

Market Talk

Gold Inches Down as Profit-Taking Seen -- Market Talk

17 Jun 2025, 17:44 UTC

Market Talk

Analysts Forecast Record-High Ethanol Output -- Market Talk

17 Jun 2025, 16:37 UTC

Market Talk

A Buy-Canadian Policy Could Support Steel Producers -- Market Talk

17 Jun 2025, 16:30 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

17 Jun 2025, 16:30 UTC

Market Talk

Canada Seen Likely to Drop Digital-Services Tax -- Market Talk

17 Jun 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

17 Jun 2025, 16:15 UTC

Market Talk

Base Metal Prices Mixed on Risk-Off Sentiment -- Market Talk

17 Jun 2025, 16:12 UTC

Market Talk

Gold Futures Fall as Safe-haven Demand Retreats -- Market Talk

17 Jun 2025, 14:54 UTC

Market Talk

Oil Rises on Continued Israel-Iran Conflict -- Market Talk

17 Jun 2025, 14:47 UTC

Market Talk

European Gas Climbs on Middle East Risks, EU Russian Ban Proposal -- Market Talk

17 Jun 2025, 14:41 UTC

Market Talk

Natural Gas Extends Climb -- Market Talk

17 Jun 2025, 14:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Peer Comparison

Price change

Cerus Corp Forecast

Price Target

By TipRanks

231.21% upside

12 Months Forecast

Average 4.67 USD  231.21%

High 5 USD

Low 4 USD

Based on 4 Wall Street analysts offering 12 month price targets forCerus Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

3

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

1.3 / 1.36Support & Resistance

Short Term

Weak Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

9 / 381 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cerus Corp

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was incorporated in 1991 and is headquartered in Concord, California.